However, it is still unclear whether CD34+ cells exhibit altered differentiation potential in the metabolic microenvironment (especially in lipid metabolism disorders) under conditions of hypertension and hyperlipidemia and whether CD34+ cells play a role in cardiac fibrosis. The gene discussed is CD34; the disease is hyperlipidemia.